Colgate-Palmolive Company Profile Avatar - Palmy Investing

Colgate-Palmolive Company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers too…
Household & Personal Products
US, New York [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 8.36 61.94 57.16
Graham Fair Price -40.02 2.28 3.81
PEG -70.32 -5.83 19.65
Price/Book 195.63 318.60 107.77
Price/Cash Flow 88.90 132.03 69.90
Prices/Earnings 17.37 26.82 22.85
Price/Sales 9.11 14.47 13.26
Price/FCF 88.90 132.03 69.90
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 0.82 0.60 0.59
Operating Margin -0.90 0.23 0.23
ROA -5.90 0.04 0.04
ROE 1.18 2.97 151.88
ROIC 0.09 0.10 3.10
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.04 0.04 6.16
Dividends QOQ 0.28 -0.22 -21.49
EBIT QOQ 0.11 0.01 -86.99
EPS QOQ 0.01 -0.05 295.40
FCF QOQ -0.05 -0.41 -679.36
Revenue QOQ < 0.005 0.02 226.25
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 86.73 84.90 -2.11
Days Sales Outstanding (DSO) 28.84 32.22 11.72
Inventory Turnover 1.04 1.06 2.15
Debt/Capitalization 0.93 0.97 4.28
Quick Ratio 0.58 0.59 2.02
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 0.74 0.28 -62.21
Cash 1.39 1.59 14.49
Capex -0.24 -0.15 35.99
Free Cash Flow 1.14 0.67 -40.85
Revenue 6.01 6.16 2.40
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.11 1.06 -4.68
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 6.28 5.83 -7.18
Naive Interpretation Member
06 - Financial Health · Bad
End of CL's Analysis
CIK: 21665 CUSIP: 194162103 ISIN: US1941621039 LEI: - UEI: -
Secondary Listings